SUMO proteomics to decipher the SUMO‐modified proteome regulated by various diseases
- 19 September 2014
- journal article
- review article
- Published by Wiley in Proteomics
- Vol. 15 (5-6) , 1181-1191
Abstract
Small ubiquitin‐like modifier (SUMO1–3) conjugation is a posttranslational protein modification whereby SUMOs are conjugated to lysine residues of target proteins. SUMO conjugation can alter the activity, stability, and function of target proteins, and thereby modulate almost all major cellular pathways. Many diseases are associated with SUMO conjugation, including heart failure, arthritis, cancer, degenerative diseases, and brain ischemia/stroke. It is, therefore, of major interest to characterize the SUMO‐modified proteome regulated by these disorders. SUMO proteomics analysis is hampered by low levels of SUMOylated proteins. Several strategies have, therefore, been developed to enrich SUMOylated proteins from cell/tissue extracts. These include proteomics analysis on cells expressing epitope‐tagged SUMO isoforms, use of monoclonal SUMO antibodies for immunoprecipitation and epitope‐specific peptides for elution, and affinity purification with peptides containing SUMO interaction motifs to specifically enrich polySUMOylated proteins. Recently, two mouse models were generated and characterized that express tagged SUMO isoforms, and allow purification of SUMOylated proteins from complex organ extracts. Ultimately, these new analytical tools will help to decipher the SUMO‐modified proteome regulated by various human diseases, and thereby, identify new targets for preventive and therapeutic purposes.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (NS081299)
- National Heart, Lung, and Blood Institute (HL095552)
- American Heart Association (12SDG11950003)
This publication has 132 references indexed in Scilit:
- Identification of protein SUMOylation sites by mass spectrometry using combined microwave‐assisted aspartic acid cleavage and tryptic digestionJournal of Mass Spectrometry, 2012
- Enhanced desumoylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunctionJournal of Molecular and Cellular Cardiology, 2012
- Analysis of Oxygen/Glucose-Deprivation-Induced Changes in SUMO3 Conjugation Using SILAC-Based Quantitative ProteomicsJournal of Proteome Research, 2011
- Systematic and Quantitative Assessment of the Ubiquitin-Modified ProteomeMolecular Cell, 2011
- A Proteomic Screen for Nucleolar SUMO Targets Shows SUMOylation Modulates the Function of Nop5/Nop58Molecular Cell, 2010
- An improved SUMmOn‐based methodology for the identification of ubiquitin and ubiquitin‐like protein conjugation sites identifies novel ubiquitin‐like protein chain linkagesProteomics, 2010
- SUMO Boosts the DNA Damage Response Barrier against CancerCancer Cell, 2010
- SUMO Regulates the Assembly and Function of a Cytoplasmic Intermediate Filament Protein in C. elegansDevelopmental Cell, 2009
- Sumoylation and human disease pathogenesisTrends in Biochemical Sciences, 2009
- Inflammation and the neurovascular unit in the setting of focal cerebral ischemiaNeuroscience, 2009